URAMIT MB (Burel Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the URAMIT MB drug offered from Burel Pharmaceuticals, Inc. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Burel Pharmaceuticals, Inc |
| NON-PROPRIETARY NAME: | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| SUBSTANCE NAME: | METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2015-06-26 |
| END MARKETING DATE: | 0000-00-00 |
URAMIT MB HUMAN PRESCRIPTION DRUG Details:
| Item Description | URAMIT MB from Burel Pharmaceuticals, Inc |
| LABELER NAME: | Burel Pharmaceuticals, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 118; 40.8; 36; 10; .12(mg/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2015-06-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 35573-300_ee12ad5a-2004-4a59-8173-20bb9eefa655 |
| PRODUCT NDC: | 35573-300 |
| APPLICATION NUMBER: | |
Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
